• Contact us
Wednesday, November 18, 2026
Register
Login
European Press
ADVERTISEMENT Handpicked deals on Amazon Discover useful products selected for our readers. Explore deals ›
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

16 November 2026
in Health
Reading Time: 3 mins read
A A
Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
ShareShareShareShareShare


NEWYou can now listen to Fox News articles!
Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.The research, published in The Lancet Psychiatry, compared 20 antidepressants to determine how well they eased depression symptoms and helped prevent them from returning over time.Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.CERTAIN SLEEP HABITS COULD OFFER CLUES TO HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAYThey found that escitalopram, sold under the brand name Lexapro; duloxetine, sold as Cymbalta; and agomelatine performed better over the long term than fluoxetine, which researchers used as the main comparison drug.Eli Lilly told Fox News Digital that it discontinued manufacturing Prozac in 2024. The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product. A new study suggests three antidepressants may work better than fluoxetine at helping people recover from depression and stay well over time. (iStock)The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.CLICK HERE FOR MORE HEALTH STORIES”Escitalopram is already widely used,” he said in the release. “Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well-known and is prescribed less frequently as a first-line treatment.”Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. These medications are often recommended as a first option for treating depression, according to the release. Researchers compared antidepressant treatments to better understand which medications may help patients maintain improvements and avoid a return of depression symptoms. (iStock)Among the SSRIs included in the study, escitalopram appeared to work best at helping patients stay well over time.Eric Ruhé, a professor of difficult-to-treat depression at Radboud University Medical Center, said the findings could eventually influence how doctors choose antidepressants. Still, the researchers stressed that this does not mean everyone with depression should take escitalopram.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER”As a prescriber, you consider the balance between a medication’s benefits and side effects,” Ruhé said in the release. “That balance differs from person to person.”Dr. Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, California, who was not involved in the study, urged caution when interpreting the findings. Escitalopram, duloxetine and agomelatine appeared to outperform fluoxetine in maintaining improvements in depression symptoms over the long term. (iStock)She noted that agomelatine is not approved in the U.S.”The best way to treat someone with depression is not always with antidepressants, and certainly not with antidepressants alone,” Lieberman told Fox News Digital.TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZPsychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy.There were some limitations to the study, the researchers acknowledged. Researchers cautioned that the findings cannot predict which antidepressant will work best for a specific patient, emphasizing the need for individualized treatment decisions. (iStock)Rather than enrolling a new group of patients and following them over time, the researchers combined results from 115 previous clinical trials to compare how the medications performed.The findings also cannot predict which antidepressant will work best for a specific person. The researchers stressed that doctors and patients should consider both the potential benefits and side effects when choosing a medication.CLICK HERE TO DOWNLOAD THE FOX NEWS APPPeople with questions about their antidepressants should speak with their doctor before making any medication changes, according to the release.Fox News Digital reached out to the researchers and additional drug manufacturers for comment. Kelly McGreal is a member of the lifestyle team at Fox News Digital. She and the team cover travel, food and drink, health, relationships and more. She also produces the weekly American Culture Quiz and handles other special projects. 

Credit: Source link

Previous Post

I’m A Celebrity 2026 star Joanna Page is the early favourite to win

Next Post

EastEnders fans raging as soap hints Sean is Oscar’s dad in bombshell twist

Recommended

LIVE:  Sweden pushes for more support for Ukraine  | Europe Today S2 #1

LIVE: Sweden pushes for more support for Ukraine | Europe Today S2 #1

17 November 2026

Why embedded DevSecOps security pays off for fast-growing startups

Why embedded DevSecOps security pays off for fast-growing startups

17 November 2026

Software startups live in a cut-throat industry where the ability to innovate rapidly is critical to growing their revenue base....

Gwen Stefani returns to Anaheim for major music debut

Gwen Stefani returns to Anaheim for major music debut

17 November 2026

Holla back. California girl Gwen Stefani is returning to her hometown of Anaheim for a very special performance early next...

49ers’ Nick Bosa has career-long sack drought, but team is not worried

49ers’ Nick Bosa has career-long sack drought, but team is not worried

17 November 2026

The San Francisco 49ers hold an 8-1 record, the best in the NFC, and yet they still haven’t gotten quite...

Datenschutzinformationen

Disclaimer  Privacy Policy – EU  Imprint 

Join European Press

Contact us

What’s New Here!

  • LIVE: Sweden pushes for more support for Ukraine | Europe Today S2 #1
  • Why embedded DevSecOps security pays off for fast-growing startups
  • Gwen Stefani returns to Anaheim for major music debut
  • 49ers’ Nick Bosa has career-long sack drought, but team is not worried

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

© 2026 European Press. All rights reserved.

European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video

© 2026 European Press. All rights reserved.

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?